NIH-funded research NIH-funded research

Molecular Control of Protein Synthesis by the eEF2K Pathway

Official title: Molecular Mechanisms of Translation Regulation by the eEF2K Pathway

Funded at University of Wisconsin-Madison · NIH-11537950 · Data updated 2026-11-12

Researchers are studying how a cellular switch called eEF2K controls protein production in cells, which could affect many diseases and brain cell function.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startSeptember 15, 2022
Project endJuly 31, 2027
Funding year2026
Award (this year)$388,750
NIH project number7R35GM146862-05
Project IDNIH-11537950 on NIH RePORTER

Who could benefit from this research

Could help

Not a patient-facing study; directly informs future therapies that could benefit patients with autoimmune diseases, cancer, or cardiovascular diseases.

Less likely to help

This grant focuses on basic mechanisms and is not a direct treatment trial for individuals.

What this research studies

This project builds a detailed, testable model of how eEF2K regulates translation at the ribosome and how signals from different pathways converge on this switch. It will map the molecular interactions and structural changes that control eEF2K activity and its downstream effects on protein synthesis, including localized regulation in specific cell types such as neurons. By understanding how eEF2K phosphorylation affects which messages are translated, the work aims to reveal why some proteins are produced in response to signals while others are suppressed. The findings could illuminate new angles for treating diseases where protein production is dysregulated, such as autoimmune diseases, cancer, and cardiovascular disorders.

Why it matters

Potential benefit: A deeper understanding of protein synthesis control could lead to new targets for therapies in autoimmune diseases, cancer, and heart conditions.

How similar studies have gone: Previous work has shown that eEF2K/eEF2 dynamics influence translation, with emerging models suggesting specific mRNA selection under certain signals.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Loerch, Sarah — University of Wisconsin-Madison
  • Study coordinator: Loerch, Sarah

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.